mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.3 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.057 |
0.3 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.052 |
0.3 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.051 |
0.3 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |